0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
In-Vitro Colorectal Cancer Screening Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: April 2024
|
Report Code: QYRE-Auto-24A8913
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global In Vitro Colorectal Cancer Screening Tests Market Size Status and Forecast 2022
BUY CHAPTERS

In-Vitro Colorectal Cancer Screening Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-24A8913
Report
April 2024
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

In-Vitro Colorectal Cancer Screening Tests - Market Size

The global market for In-Vitro Colorectal Cancer Screening Tests was estimated to be worth US$ 1044.9 million in 2023 and is forecast to a readjusted size of US$ 1526.7 million by 2030 with a CAGR of 5.5% during the forecast period 2024-2030

In-Vitro Colorectal Cancer Screening Tests - Market

In-Vitro Colorectal Cancer Screening Tests - Market

In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.
The industry's leading producers are Alere(Abbott), Beckman Coulter and Siemens Healthcare, which accounted for 31.59%, 18.71% and 10.67% of revenue in 2019, respectively.

Report Scope

This report aims to provide a comprehensive presentation of the global market for In-Vitro Colorectal Cancer Screening Tests, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of In-Vitro Colorectal Cancer Screening Tests by region & country, by Type, and by Application.
The In-Vitro Colorectal Cancer Screening Tests market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Vitro Colorectal Cancer Screening Tests.
Market Segmentation

Scope of In-Vitro Colorectal Cancer Screening Tests - Market Report

Report Metric Details
Report Name In-Vitro Colorectal Cancer Screening Tests - Market
Forecasted market size in 2030 US$ 1526.7 million
CAGR 5.5%
Forecasted years 2024 - 2030
Segment by Type:
  • Biomarker Tests
  • Fecal Occult Blood Tests
  • CRC DNA Screening Tests
Segment by Application
  • Hospital and Clinics
  • Ambulatory
  • Home Care
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Alere(Abbott), Beckman Coulter, Siemens Healthcare, Eiken Chemical, Hitachi Chemical (Kyowa Medex), Clinical Genomics Pty Ltd (Quest Diagnostics), Sysmex, QIAGEN, R-Biopharm, Immunostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of In-Vitro Colorectal Cancer Screening Tests manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of In-Vitro Colorectal Cancer Screening Tests in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of In-Vitro Colorectal Cancer Screening Tests in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the In-Vitro Colorectal Cancer Screening Tests - Market size in 2030?

Ans: The In-Vitro Colorectal Cancer Screening Tests - Market size in 2030 will be US$ 1526.7 million.

What is the Alere(Abbott) share in In-Vitro Colorectal Cancer Screening Tests - Market?

Ans: The industry's leading producers are Alere(Abbott), Beckman Coulter and Siemens Healthcare, which accounted for 31.59%, 18.71% and 10.67% of revenue in 2019, respectively.

Who are the main players in the In-Vitro Colorectal Cancer Screening Tests - Market report?

Ans: The main players in the In-Vitro Colorectal Cancer Screening Tests - Market are Alere(Abbott), Beckman Coulter, Siemens Healthcare, Eiken Chemical, Hitachi Chemical (Kyowa Medex), Clinical Genomics Pty Ltd (Quest Diagnostics), Sysmex, QIAGEN, R-Biopharm, Immunostics

What are the Application segmentation covered in the In-Vitro Colorectal Cancer Screening Tests - Market report?

Ans: The Applications covered in the In-Vitro Colorectal Cancer Screening Tests - Market report are Hospital and Clinics, Ambulatory, Home Care

What are the Type segmentation covered in the In-Vitro Colorectal Cancer Screening Tests - Market report?

Ans: The Types covered in the In-Vitro Colorectal Cancer Screening Tests - Market report are Biomarker Tests, Fecal Occult Blood Tests, CRC DNA Screening Tests

1 Market Overview
1.1 In-Vitro Colorectal Cancer Screening Tests Product Introduction
1.2 Global In-Vitro Colorectal Cancer Screening Tests Market Size Forecast
1.3 In-Vitro Colorectal Cancer Screening Tests Market Trends & Drivers
1.3.1 In-Vitro Colorectal Cancer Screening Tests Industry Trends
1.3.2 In-Vitro Colorectal Cancer Screening Tests Market Drivers & Opportunity
1.3.3 In-Vitro Colorectal Cancer Screening Tests Market Challenges
1.3.4 In-Vitro Colorectal Cancer Screening Tests Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global In-Vitro Colorectal Cancer Screening Tests Players Revenue Ranking (2023)
2.2 Global In-Vitro Colorectal Cancer Screening Tests Revenue by Company (2019-2024)
2.3 Key Companies In-Vitro Colorectal Cancer Screening Tests Manufacturing Base Distribution and Headquarters
2.4 Key Companies In-Vitro Colorectal Cancer Screening Tests Product Offered
2.5 Key Companies Time to Begin Mass Production of In-Vitro Colorectal Cancer Screening Tests
2.6 In-Vitro Colorectal Cancer Screening Tests Market Competitive Analysis
2.6.1 In-Vitro Colorectal Cancer Screening Tests Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by In-Vitro Colorectal Cancer Screening Tests Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Colorectal Cancer Screening Tests as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Biomarker Tests
3.1.2 Fecal Occult Blood Tests
3.1.3 CRC DNA Screening Tests
3.2 Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Type
3.2.1 Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global In-Vitro Colorectal Cancer Screening Tests Sales Value, by Type (2019-2030)
3.2.3 Global In-Vitro Colorectal Cancer Screening Tests Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital and Clinics
4.1.2 Ambulatory
4.1.3 Home Care
4.2 Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Application
4.2.1 Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global In-Vitro Colorectal Cancer Screening Tests Sales Value, by Application (2019-2030)
4.2.3 Global In-Vitro Colorectal Cancer Screening Tests Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Region
5.1.1 Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Region (2019-2024)
5.1.3 Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Region (2025-2030)
5.1.4 Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America In-Vitro Colorectal Cancer Screening Tests Sales Value, 2019-2030
5.2.2 North America In-Vitro Colorectal Cancer Screening Tests Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe In-Vitro Colorectal Cancer Screening Tests Sales Value, 2019-2030
5.3.2 Europe In-Vitro Colorectal Cancer Screening Tests Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific In-Vitro Colorectal Cancer Screening Tests Sales Value, 2019-2030
5.4.2 Asia Pacific In-Vitro Colorectal Cancer Screening Tests Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America In-Vitro Colorectal Cancer Screening Tests Sales Value, 2019-2030
5.5.2 South America In-Vitro Colorectal Cancer Screening Tests Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Sales Value, 2019-2030
5.6.2 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions In-Vitro Colorectal Cancer Screening Tests Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions In-Vitro Colorectal Cancer Screening Tests Sales Value
6.3 United States
6.3.1 United States In-Vitro Colorectal Cancer Screening Tests Sales Value, 2019-2030
6.3.2 United States In-Vitro Colorectal Cancer Screening Tests Sales Value by Type (%), 2023 VS 2030
6.3.3 United States In-Vitro Colorectal Cancer Screening Tests Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe In-Vitro Colorectal Cancer Screening Tests Sales Value, 2019-2030
6.4.2 Europe In-Vitro Colorectal Cancer Screening Tests Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe In-Vitro Colorectal Cancer Screening Tests Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China In-Vitro Colorectal Cancer Screening Tests Sales Value, 2019-2030
6.5.2 China In-Vitro Colorectal Cancer Screening Tests Sales Value by Type (%), 2023 VS 2030
6.5.3 China In-Vitro Colorectal Cancer Screening Tests Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan In-Vitro Colorectal Cancer Screening Tests Sales Value, 2019-2030
6.6.2 Japan In-Vitro Colorectal Cancer Screening Tests Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan In-Vitro Colorectal Cancer Screening Tests Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea In-Vitro Colorectal Cancer Screening Tests Sales Value, 2019-2030
6.7.2 South Korea In-Vitro Colorectal Cancer Screening Tests Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea In-Vitro Colorectal Cancer Screening Tests Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia In-Vitro Colorectal Cancer Screening Tests Sales Value, 2019-2030
6.8.2 Southeast Asia In-Vitro Colorectal Cancer Screening Tests Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia In-Vitro Colorectal Cancer Screening Tests Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India In-Vitro Colorectal Cancer Screening Tests Sales Value, 2019-2030
6.9.2 India In-Vitro Colorectal Cancer Screening Tests Sales Value by Type (%), 2023 VS 2030
6.9.3 India In-Vitro Colorectal Cancer Screening Tests Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Alere(Abbott)
7.1.1 Alere(Abbott) Profile
7.1.2 Alere(Abbott) Main Business
7.1.3 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
7.1.4 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) & (2019-2024)
7.1.5 Alere(Abbott) Recent Developments
7.2 Beckman Coulter
7.2.1 Beckman Coulter Profile
7.2.2 Beckman Coulter Main Business
7.2.3 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
7.2.4 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) & (2019-2024)
7.2.5 Beckman Coulter Recent Developments
7.3 Siemens Healthcare
7.3.1 Siemens Healthcare Profile
7.3.2 Siemens Healthcare Main Business
7.3.3 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
7.3.4 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) & (2019-2024)
7.3.5 Eiken Chemical Recent Developments
7.4 Eiken Chemical
7.4.1 Eiken Chemical Profile
7.4.2 Eiken Chemical Main Business
7.4.3 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
7.4.4 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) & (2019-2024)
7.4.5 Eiken Chemical Recent Developments
7.5 Hitachi Chemical (Kyowa Medex)
7.5.1 Hitachi Chemical (Kyowa Medex) Profile
7.5.2 Hitachi Chemical (Kyowa Medex) Main Business
7.5.3 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
7.5.4 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) & (2019-2024)
7.5.5 Hitachi Chemical (Kyowa Medex) Recent Developments
7.6 Clinical Genomics Pty Ltd (Quest Diagnostics)
7.6.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Profile
7.6.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Main Business
7.6.3 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
7.6.4 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) & (2019-2024)
7.6.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments
7.7 Sysmex
7.7.1 Sysmex Profile
7.7.2 Sysmex Main Business
7.7.3 Sysmex In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
7.7.4 Sysmex In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) & (2019-2024)
7.7.5 Sysmex Recent Developments
7.8 QIAGEN
7.8.1 QIAGEN Profile
7.8.2 QIAGEN Main Business
7.8.3 QIAGEN In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
7.8.4 QIAGEN In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) & (2019-2024)
7.8.5 QIAGEN Recent Developments
7.9 R-Biopharm
7.9.1 R-Biopharm Profile
7.9.2 R-Biopharm Main Business
7.9.3 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
7.9.4 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) & (2019-2024)
7.9.5 R-Biopharm Recent Developments
7.10 Immunostics
7.10.1 Immunostics Profile
7.10.2 Immunostics Main Business
7.10.3 Immunostics In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
7.10.4 Immunostics In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) & (2019-2024)
7.10.5 Immunostics Recent Developments
8 Industry Chain Analysis
8.1 In-Vitro Colorectal Cancer Screening Tests Industrial Chain
8.2 In-Vitro Colorectal Cancer Screening Tests Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 In-Vitro Colorectal Cancer Screening Tests Sales Model
8.5.2 Sales Channel
8.5.3 In-Vitro Colorectal Cancer Screening Tests Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. In-Vitro Colorectal Cancer Screening Tests Market Trends
    Table 2. In-Vitro Colorectal Cancer Screening Tests Market Drivers & Opportunity
    Table 3. In-Vitro Colorectal Cancer Screening Tests Market Challenges
    Table 4. In-Vitro Colorectal Cancer Screening Tests Market Restraints
    Table 5. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies In-Vitro Colorectal Cancer Screening Tests Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies In-Vitro Colorectal Cancer Screening Tests Product Type
    Table 9. Key Companies Time to Begin Mass Production of In-Vitro Colorectal Cancer Screening Tests
    Table 10. Global In-Vitro Colorectal Cancer Screening Tests Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Colorectal Cancer Screening Tests as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global In-Vitro Colorectal Cancer Screening Tests Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global In-Vitro Colorectal Cancer Screening Tests Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global In-Vitro Colorectal Cancer Screening Tests Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global In-Vitro Colorectal Cancer Screening Tests Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Region (2019-2024) & (%)
    Table 27. Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions In-Vitro Colorectal Cancer Screening Tests Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions In-Vitro Colorectal Cancer Screening Tests Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions In-Vitro Colorectal Cancer Screening Tests Sales Value, (2025-2030) & (US$ Million)
    Table 31. Alere(Abbott) Basic Information List
    Table 32. Alere(Abbott) Description and Business Overview
    Table 33. Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
    Table 34. Revenue (US$ Million) in In-Vitro Colorectal Cancer Screening Tests Business of Alere(Abbott) (2019-2024)
    Table 35. Alere(Abbott) Recent Developments
    Table 36. Beckman Coulter Basic Information List
    Table 37. Beckman Coulter Description and Business Overview
    Table 38. Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
    Table 39. Revenue (US$ Million) in In-Vitro Colorectal Cancer Screening Tests Business of Beckman Coulter (2019-2024)
    Table 40. Beckman Coulter Recent Developments
    Table 41. Siemens Healthcare Basic Information List
    Table 42. Siemens Healthcare Description and Business Overview
    Table 43. Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
    Table 44. Revenue (US$ Million) in In-Vitro Colorectal Cancer Screening Tests Business of Siemens Healthcare (2019-2024)
    Table 45. Siemens Healthcare Recent Developments
    Table 46. Eiken Chemical Basic Information List
    Table 47. Eiken Chemical Description and Business Overview
    Table 48. Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
    Table 49. Revenue (US$ Million) in In-Vitro Colorectal Cancer Screening Tests Business of Eiken Chemical (2019-2024)
    Table 50. Eiken Chemical Recent Developments
    Table 51. Hitachi Chemical (Kyowa Medex) Basic Information List
    Table 52. Hitachi Chemical (Kyowa Medex) Description and Business Overview
    Table 53. Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
    Table 54. Revenue (US$ Million) in In-Vitro Colorectal Cancer Screening Tests Business of Hitachi Chemical (Kyowa Medex) (2019-2024)
    Table 55. Hitachi Chemical (Kyowa Medex) Recent Developments
    Table 56. Clinical Genomics Pty Ltd (Quest Diagnostics) Basic Information List
    Table 57. Clinical Genomics Pty Ltd (Quest Diagnostics) Description and Business Overview
    Table 58. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
    Table 59. Revenue (US$ Million) in In-Vitro Colorectal Cancer Screening Tests Business of Clinical Genomics Pty Ltd (Quest Diagnostics) (2019-2024)
    Table 60. Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments
    Table 61. Sysmex Basic Information List
    Table 62. Sysmex Description and Business Overview
    Table 63. Sysmex In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
    Table 64. Revenue (US$ Million) in In-Vitro Colorectal Cancer Screening Tests Business of Sysmex (2019-2024)
    Table 65. Sysmex Recent Developments
    Table 66. QIAGEN Basic Information List
    Table 67. QIAGEN Description and Business Overview
    Table 68. QIAGEN In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
    Table 69. Revenue (US$ Million) in In-Vitro Colorectal Cancer Screening Tests Business of QIAGEN (2019-2024)
    Table 70. QIAGEN Recent Developments
    Table 71. R-Biopharm Basic Information List
    Table 72. R-Biopharm Description and Business Overview
    Table 73. R-Biopharm In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
    Table 74. Revenue (US$ Million) in In-Vitro Colorectal Cancer Screening Tests Business of R-Biopharm (2019-2024)
    Table 75. R-Biopharm Recent Developments
    Table 76. Immunostics Basic Information List
    Table 77. Immunostics Description and Business Overview
    Table 78. Immunostics In-Vitro Colorectal Cancer Screening Tests Products, Services and Solutions
    Table 79. Revenue (US$ Million) in In-Vitro Colorectal Cancer Screening Tests Business of Immunostics (2019-2024)
    Table 80. Immunostics Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. In-Vitro Colorectal Cancer Screening Tests Downstream Customers
    Table 84. In-Vitro Colorectal Cancer Screening Tests Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. In-Vitro Colorectal Cancer Screening Tests Product Picture
    Figure 2. Global In-Vitro Colorectal Cancer Screening Tests Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global In-Vitro Colorectal Cancer Screening Tests Sales Value (2019-2030) & (US$ Million)
    Figure 4. In-Vitro Colorectal Cancer Screening Tests Report Years Considered
    Figure 5. Global In-Vitro Colorectal Cancer Screening Tests Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by In-Vitro Colorectal Cancer Screening Tests Revenue in 2023
    Figure 7. In-Vitro Colorectal Cancer Screening Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Biomarker Tests Picture
    Figure 9. Fecal Occult Blood Tests Picture
    Figure 10. CRC DNA Screening Tests Picture
    Figure 11. Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global In-Vitro Colorectal Cancer Screening Tests Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Hospital and Clinics
    Figure 14. Product Picture of Ambulatory
    Figure 15. Product Picture of Home Care
    Figure 16. Global In-Vitro Colorectal Cancer Screening Tests Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global In-Vitro Colorectal Cancer Screening Tests Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America In-Vitro Colorectal Cancer Screening Tests Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America In-Vitro Colorectal Cancer Screening Tests Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe In-Vitro Colorectal Cancer Screening Tests Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe In-Vitro Colorectal Cancer Screening Tests Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America In-Vitro Colorectal Cancer Screening Tests Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America In-Vitro Colorectal Cancer Screening Tests Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions In-Vitro Colorectal Cancer Screening Tests Sales Value (%), (2019-2030)
    Figure 29. United States In-Vitro Colorectal Cancer Screening Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States In-Vitro Colorectal Cancer Screening Tests Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States In-Vitro Colorectal Cancer Screening Tests Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe In-Vitro Colorectal Cancer Screening Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe In-Vitro Colorectal Cancer Screening Tests Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe In-Vitro Colorectal Cancer Screening Tests Sales Value by Application (%), 2023 VS 2030
    Figure 35. China In-Vitro Colorectal Cancer Screening Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China In-Vitro Colorectal Cancer Screening Tests Sales Value by Type (%), 2023 VS 2030
    Figure 37. China In-Vitro Colorectal Cancer Screening Tests Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan In-Vitro Colorectal Cancer Screening Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan In-Vitro Colorectal Cancer Screening Tests Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan In-Vitro Colorectal Cancer Screening Tests Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea In-Vitro Colorectal Cancer Screening Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea In-Vitro Colorectal Cancer Screening Tests Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea In-Vitro Colorectal Cancer Screening Tests Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia In-Vitro Colorectal Cancer Screening Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia In-Vitro Colorectal Cancer Screening Tests Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia In-Vitro Colorectal Cancer Screening Tests Sales Value by Application (%), 2023 VS 2030
    Figure 47. India In-Vitro Colorectal Cancer Screening Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India In-Vitro Colorectal Cancer Screening Tests Sales Value by Type (%), 2023 VS 2030
    Figure 49. India In-Vitro Colorectal Cancer Screening Tests Sales Value by Application (%), 2023 VS 2030
    Figure 50. In-Vitro Colorectal Cancer Screening Tests Industrial Chain
    Figure 51. In-Vitro Colorectal Cancer Screening Tests Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS